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Abstract
Mycobacterium tuberculosis (Mtb) and filarial coinfection is highly prevalent, and the presence of filarial infections may
regulate the Toll-like receptor (TLR)-dependent immune response needed to control Mtb infection. By analyzing the
baseline and mycobacterial antigen–stimulated expression of TLR1, 2, 4, and 9 (in individuals with latent tuberculosis [TB]
with or without filarial infection), we were able to demonstrate that filarial infection, coincident with Mtb, significantly
diminishes both baseline and Mtb antigen-specific TLR2 and TLR9 expression. In addition, pro-inflammatory cytokine
responses to TLR2 and 9 ligands are significantly diminished in filaria/TB-coinfected individuals. Definitive treatment of
lymphatic filariasis significantly restores the pro-inflammatory cytokine responses in individuals with latent TB. Coincident
filarial infection exerted a profound inhibitory effect on protective mycobacteria-specific TLR-mediated immune responses
in latent tuberculosis and suggests a novel mechanism by which concomitant filarial infections predispose to the
development of active tuberculosis in humans.
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Introduction
Lymphatic filariasis is a disease that afflicts over 120 million
people worldwide. The parasites that cause the infection
(Wuchereria bancrofti, Brugia malayi, and Brugia timori) are long lived
and often induce asymptomatic (or subclinical) infections due, in
large part, to the parasites’ ability to manipulate the host immune
system and to restrict inflammatory pathology [1]. Modulation of
the host immune response involves a variety of strategies, including
induction of regulatory networks and dysregulation of innate and
adaptive immune responses [2]. Chronic filarial infections are
associated with diminished expression and function of Toll-like
receptors (TLRs) on antigen-presenting cells (APCs) and T cells
[3,4]. While the immune modulation associated with systemic
filarial infections is primarily parasite-antigen specific, some
bystander effects on routine vaccinations, allergic processes, and
autoimmune diseases have been noted [5]. We have shown
recently that filarial infection coincident with Mycobacterium
tuberculosis (Mtb) infection significantly diminishes Mtb-specific
Th1 (IL-12/IFN-c) and Th17 (IL-23/IL-17) responses related to
increased CTLA-4 and PD-1 expression (manuscript in press).
Mtb infects ,2 billion people worldwide, with 90% of Mtb-
infected individuals having latent infection. TLR signaling has been
postulated to play an important role in the host resistance to Mtb
[6,7]. The control of tuberculosis (TB) requires clearly delineated
Th1 responses (IL-12, IFN-c, and TNF-a) and, to a lesser extent,
Th17 responses (IL-17 and IL-23) [8]. Mtb and other mycobacteria
contain well characterized TLR ligands that are potent in vitro
stimuli of a number of proinflammatory cytokines including TNF-a
and IL-12 [6]. A role for TLR signaling in host resistance to Mtb is
further supported by the observation that mice deficient in MyD88,
a major adaptor molecule required for signaling events by most
TLR/IL-1R family members, show greatly enhanced susceptibility
to aerosol infection with Mtb, equivalent to that observed with IFN-
c-deficient mice [9,10,11]. Infected MyD882/2 animals, in
addition to their loss of resistance to Mtb, display impaired
proinflammatory cytokine synthesis, which was found to correlate
with decreased nitric oxide synthase 2 expression and diminished
IFN-c synthesis [9,10,11]. In addition, TLR2 and 9 have been
found to be essential in mediating immunity to Mtb [12].
Because filarial infections and TB are co-endemic in many parts
of the world, we hypothesized that immune responses in latent TB
could be modulated by diminished TLR expression and function
induced by chronic, coexisting filarial infections. To this end, we
examined the baseline and Mtb-specific expression of TLR1, 2, 4,
and 9, as well as the induction of pro-inflammatory cytokines by
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TLR ligands. We observed that the presence of patent filarial
infection altered profoundly the TLR-mediated cytokine responses
in individuals with coexisting latent Mtb, an immune modulation
that is reversible following treatment of the filarial infection.
Methods
Study population
We studied a group of 9 patients who were tuberculin skin test
positive (PPD+) but filarial infection2 (hereafter PPD+Fil2) and 9
who were PPD+ and filarial infection+ (hereafter PPD+Fil+) in
Tamil Nadu, South India (Table 1). Filarial infection was
diagnosed by the presence of circulating filarial antigen first by
using the ICT filarial antigen test (Binax, Portland, ME, USA) and
then confirmed by positivity in the Trop Bio Og4C3 ELISA (Trop
Bio Pty. Ltd, Townsville, Queensland, Australia). All subjects had
positive skin test reactivity to intradermal tuberculin (2 TU). A
positive tuberculin skin test was defined as an induration at the site
of inoculation of at least 12-mm diameter to account for the high
prevalence of environmental mycobacteria. This was based on the
fact that a rigorous multivariate analysis of 280,000 subjects over a
15-year follow-up had previously demonstrated that subjects with
0–11-mm tuberculin skin test reaction to 2 TU PPD-S comprised
the predominantly uninfected group and subjects with 12-mm or
greater tuberculin skin test reaction comprised the predominantly
infected group in South India [13]. All subjects had normal chest
radiographs. None of the subjects had pulmonary symptoms
(cough, fever, chest pain, hemoptysis) or a positive sputum for Mtb
by smear microscopy and culture. All individuals were examined
as part of a clinical protocol (NCT 01-I-N261) approved by
Institutional Review Boards of both the National Institute of
Allergy and Infectious Diseases and the Tuberculosis Research
Center, and informed written consent was obtained from all
participants. Fil+ individuals were treated with diethylcarbamazine
(300 mg) per day for 7 days and a single dose of albendazole
(400 mg) administered on the first day. Post treatment assessment
of immune responses was performed 1 year following treatment.
Isolation of peripheral blood mononuclear cells (PBMCs)
Heparinized blood was collected and PBMCs isolated by Ficoll
diatrizoate gradient centrifugation (LSM; ICN Biomedicals,
Aurora, OH, USA). Erythrocytes were lysed using ACK lysis
buffer (Biosource International, Camarillo, CA, USA). Cells were
then washed and cultured in RPMI-1640 (BioWhittaker, Walk-
ersville, MD, USA), supplemented with 20 mM glutamine
(BioWhittaker), 10% heat-inactivated FCS (Harlan Bioproducts
for Science, Madison, WI, USA), and 50 mg/ml of gentamycin
(Mediatech, Herndon, VA, USA).
Antigens
Mycobacterial PPD (Statens Serum Institute, Copenhagen,
Denmark), Mtb-culture filtrate protein (CFP, kind gift of Dr. P.
Selvaraj, Tuberculosis Research Center, Chennai, India) and
tetanus toxoid (TT) were used as the antigenic stimuli. The TLR
ligands (Invivogen, San Diego, CA, USA) used were: TLR2 ligand,
Pam3CysSerLys4 (hereafter Pam3Cys); TLR4 ligand, ultrapure
LPS; and TLR9 ligand, CpG ODN M362 (hereafter ODN).
In vitro culture
PBMCs were cultured with PPD (10 mg/ml) or Mtb CFP
(10 mg/ml) or TT (10 mg/ml) in 24-well tissue culture plates
Author Summary
Lymphatic filariasis afflicts over 120 million people
worldwide, while Mycobacterium tuberculosis infects over
2 billion people worldwide. Almost 90% of infected people
harbor latent tuberculosis infection with no clinical
manifestations. Toll-like receptors (TLRs), pattern-recogni-
tion receptors that are present on host immune cells,
constitute an important facet of host immune response
initiation against a variety of pathogens. Because lym-
phatic filariasis and tuberculosis are co-endemic in many
parts of the world and because TLR modulation is an
important feature of both infections, we examined the
effect of coexisting filarial infection on TLR-specific
immune responses in latent tuberculosis by comparing
cellular immune responses to Toll ligands in individuals
with latent tuberculosis with or without concomitant
lymphatic filariasis. We first examined modulation of TLRs
at the gene expression level and determined that
downregulation of TLR2 and 9 is associated with coexisting
filarial infection. We then determined that Toll ligand-
induced pro-inflammatory cytokine production—which is
crucial in host defense against TB—is diminished in the
presence of filarial coinfection. Treatment of filarial
infection restores cytokine production in individuals with
latent TB. Thus, we conclude that coexisting filarial
infections might significantly compromise essential im-
mune responses in tuberculosis and that treatment of
filarial infections would potentially confer tremendous
benefit in combating tuberculosis.
Table 1. Characteristics of the study population.
PPD+Fil2 (n =9) PPD+Fil+ (n =9)
Median age (range) 48 (30–66) 42 (25–55)
Gender M / F 4 / 5 6 / 3
Treatment No Yes
Pathology None None
Tuberculosis skin test reaction (TU) .12 mm .12 mm
ICT card test All 2 All +
W. bancrofti circulating antigen levels U/ml (median) ,32 (,32) 177–32768 (3320)
W. bancrofti circulating antigen levels U/ml (median) – post treatment NA NA 107–32768 (1024)
The lower limit of the assay detection was 32 U/ml.
NA , not applicable.
doi:10.1371/journal.pntd.0000489.t001
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(Corning, Corning, NY, USA) at concentrations of 56106/well.
After 24 hours, RNA was isolated and examined for TLR gene
expression. PBMCs were also cultured with Pam3Cys (10 mg/ml),
ultrapure LPS (10 mg/ml), or ODN (5 mM). After 24 hours,
culture supernatants were collected and analyzed for cytokines.
ELISA
The levels of cytokines in the culture supernatants were
measured using Bioplex multiplex cytokine assay system (Bio-
Rad, Hercules, CA, USA). The cytokines analyzed were IFN-c,
TNF-a, IL-12p70, IL-6, and IL-1b.
RNA preparation
PBMCs were lysed using the reagents of a commercial kit
(QIAshredder; Qiagen, Valencia, CA, USA). Total RNA was
extracted according to the manufacturer’s protocol (RNeasy mini
kit; Qiagen), and RNA was dissolved in 50 ml of RNase-free water.
cDNA synthesis
RNA (1 mg) was used to generate cDNA using TaqMan reverse
transcription reagents according to the manufacturer’s protocol
(Applied Biosystems, Inc., Fullerton, CA, USA). Briefly, random
hexamers were used to prime RNA samples for reverse
transcription using MultiScribe reverse transcriptase.
Real-time RT-PCR
Real-time quantitative RT-PCR was performed in an ABI 7500
sequence detection system (Applied Biosystems) using TaqMan
Assays-on-Demand reagents for TLR1, 2, 4, and 9 and an
endogenous 18 s ribosomal RNA control. Relative transcripts
were determined by the formula
1
.
2 CTtarget{CTcontrolð Þ,
where CT is the threshold cycle during the exponential phase of
amplification.
Statistical analysis
Geometric mean was used as the measure of central tendency.
Comparisons were made using either the Mann-Whitney U test
(for unpaired data), the Wilcoxon signed rank test (for paired data),
or Spearman rank correlation. All statistics were performed using
GraphPad Prism version 5 for Windows.
Results
Filarial infection is associated with decreased baseline
and Mtb-specific TLR2 and 9 expression in latent TB
To determine the impact of coexisting filarial infection on
baseline and antigen-specific TLR expression of PPD+ individuals,
and because filarial infection is associated with diminished
expression of TLR1, 2, 4, and 9 [3], we examined the mRNA
expression of these TLRs from PPD+Fil2 or PPD+Fil+ individuals
ex vivo as well as following PBMC stimulation with PPD or
culture-filtrate antigen from Mtb H37 Rv (Mtb CFP) or TT for
24 hours by RT-PCR. Both baseline (Figure 1A) as well as PPD-
(Figure 1B) and Mtb CFP-specific (Figure 1C) induction of TLR2
and 9 was significantly lower in PPD+Fil+ patients (TLR2:
geometric mean [GM] of 0.7373 in PPD+Fil+ vs. 0.7973 in
PPD+Fil2 at baseline [P= 0.0340]; GM fold change of 0.9469 in
PPD+Fil+ vs. 2.513 in PPD+Fil2 for PPD [P= 0.0040]; GM fold
change of 0.5866 vs. 4.127 for CFP [P,0.0001] TLR9: GM of
0.5523 vs. 05889 at baseline [P= 0.0244]; GM fold change of
0.7660 vs. 2.834 for PPD [P= 0.0040]; GM fold change of 0.6989
vs. 2.297 for CFP [P= 0.0134]) compared with the PPD+Fil2
group. TT-specific TLR expression was examined as a control to
TB antigens and did not exhibit any significant difference in
expression (Figure 1D).
Filarial infection is associated with diminished Pam3Cys
and ODN - specific pro-inflammatory cytokine
production in latent TB
To determine the impact of coexisting filarial infection on TLR-
specific pro-inflammatory cytokine responses in PPD+ individuals,
we stimulated PBMC from PPD+Fil2 or PPD+Fil+ with Pam3Cys
(TLR2 ligand), ODN (TLR9 ligand), or LPS (TLR4 ligand) for
24 hours and measured the levels of IL-1b, TNF-a, IL-6, IL-12,
and IFN-c. As shown in Figure 2A and B, Pam3Cys and ODN
induced significantly lower levels of IL-1b (GM of 33.60 pg/ml in
PPD+Fil+ vs. 283.9 pg/ml in PPD+Fil2 for Pam3Cys [P= 0.0566];
GM of 16.61 pg/ml vs. 9.66 pg/ml for ODN [P=0.0078]), TNF-
a (GM of 91.19 pg/ml vs. 338.9 pg/ml for Pam3Cys [P= 0.0244];
GM of 76.99 pg/ml vs. 260.1 pg/ml for ODN [P=0.0142]), IL-6
(GM of 511.1 pg/ml vs. 2157 pg/ml for Pam3Cys [P= 0.0142];
GM of 90.20 pg/ml vs. 295.6 pg/ml for ODN [P= 0.0770, not
significant]), IL-12 (GM of 15.17 pg/ml vs. 21.37 pg/ml for
Pam3Cys [P= 0.0315]; GM of 13.15 pg/ml vs. 32.12 pg/ml for
ODN [P= 0.0188]) and IFN-c (GM of 72.54 pg/ml vs. 237.1 pg/
ml for Pam3Cys [P= 0.0188]; GM of 29.86 pg/ml vs. 294.4 pg/
ml for ODN [P=0.0040]) in the PPD+Fil+ compared with the
PPD+Fil2 group. There were no significant differences in the
production of the above-mentioned cytokines (Figure 2C) in
response to LPS.
Treatment of filarial infection is associated with
enhanced Pam3Cys and ODN - specific pro-inflammatory
cytokine production in latent TB
To determine whether antifilarial treatment could reverse the
attenuated TLR-specific pro-inflammatory cytokine responses in
PPD+ individuals with concomitant lymphatic filariasis, we
stimulated PBMCs from PPD+Fil+, pre- and 1 year post-treatment,
with Pam3Cys, ODN, or LPS for 24 hours and measured the levels
of IL-1b, TNF-a, IL-6, IL-12, and IFN-c. As shown in Figure 3A
and B (and in comparison to pretreatment responses), Pam3Cys and
ODN induced significantly increased production of IL-1b (GM of
31 pg/ml in pretreatment vs. 198.3 pg/ml post treatment for
Pam3Cys [P= 0.0117]; GM of 16.61 pg/ml vs. 47.83 pg/ml for
ODN [P=0.0547, not significant]), TNF-a (GM of 91.19 pg/ml
vs. 728.2 pg/ml for Pam3Cys [P= 0.0273]; GM of 72.73 pg/ml vs.
247.4 pg/ml for ODN [P=0.0195]), IL-6 (GM of 511.1 pg/ml vs.
1396 pg/ml for Pam3Cys [P= 0.1289, not significant]; GM of
90.20 pg/ml vs. 418.1 pg/ml for ODN [P=0.0195]), IL-12 (GM
of 15.17 pg/ml vs. 105.4 pg/ml for Pam3Cys [P= 0.0391]; GM
of 13.15 pg/ml vs. 53.46 pg/ml for ODN [P=0.0390]) and IFN-c
(GM of 72.54 pg/ml vs. 201.4 pg/ml for Pam3Cys [P= 0.0195];
GM of 27.89 pg/ml vs. 174.6 pg/ml for ODN [P=0.0273]) in the
PPD+Fil+ group. Filarial infection treatment had minimal impact on
LPS-induced production of the above-mentioned cytokines except
IL-1b (P = 0.0391), which also showed an increase following
antifilarial treatment (Figure 3C). Finally, as shown in Figure 3D,
there was a strong relationship between the decrease in the
circulating filarial antigen levels, a surrogate marker of treatment
efficacy, and the increase in TNF-a and IFN-c levels in response to
Pam3Cys (P= 0.0045 and r= 0.8667 for TNF-a, and P=0.0311
and r= 0.7333 for IFN-c) and to ODN (P=0.0061 and r= 0.8500
TLR Modulation in Filaria/TB Coinfection
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for TNF-a, and P=0.0045 and r= 0.8667 for IFN-c) following
antifilarial treatment.
Discussion
Parasitic helminths have evolved mechanisms to overcome and
evade host immune responses to thrive in immune-exposed
locations such as lymphatics, bloodstream, and gastrointestinal
tract [2]. Most helminth infections induce relatively little disease in
spite of extraordinarily high loads of infection. This subversion
of the host immune response is achieved through induction of
multiple layers of immunoregulation [2]. The interactions of
helminth parasites with APCs are known to involve TLRs [14],
pattern-recognition receptors that form a key component of
microbial detection and host defense and are important in the
initiation of host immune responses [15]. TLRs are involved in
recognition of a wide spectrum of pathogens by binding to
pathogen-associated molecular patterns [16]. In addition, TLRs
control multiple APC functions and activate signals critically
involved in the initiation of adaptive immune responses [17].
Downregulation of TLR-mediated immune responses—through
dampening TLR-mediated cell signaling or through diminished
TLR expression—appears to be an important immune evasion
mechanism in some bacterial pathogens as well as in helminth
infections [14,18]. Thus, children with schistosomiasis have
diminished responses to TLR ligands compared with uninfected
children in the same endemic area [19]. Similarly, individuals with
filarial infection have diminished expression of APC- and T cell-
specific-TLR1, 2, 4, and 9 as well as decreased pro-inflammatory
cytokine responses to TLR2, 4, and 9 ligands [3,4].
Because immune-mediated protection against Mtb is charac-
terized by strong Mycobacterium-specific Th1 responses [20], it
has been postulated that coincident infections with helminth
parasites could modulate these immune responses by driving Th2
and/or regulatory T cells that induce antiinflammatory responses
[5]. Indeed, we have previously shown that filarial infection
coincident with Mtb significantly diminishes Mtb-specific Th1 (IL-
12/IFN-c) and Th17 (IL-23/IL-17) responses related to increased
expression of CTLA-4 and PD-1 [21]. Others have also shown
that the poor immunogenicity of bacillus Calmette-Gue´rin
vaccination in helminth-infected populations is associated with
elevated TGFb production [22]. Because filarial infections and
Figure 1. Filarial infection is associated with decreased expression of TLR2 and TLR9 at baseline and following PPD and CFP
stimulation in latent TB patients. PBMC from PPD+Fil2 (n= 9) and PPD+Fil+ (n=9) patients were examined at baseline (A) or stimulated with PPD
(B) or Mtb CFP (C) or TT (D) for 24 hours, and TLR1, 2, 4, and 9 mRNA levels were measured by real-time RT-PCR. Results are shown as relative
expression at baseline (A) or fold change over media control (B, C, and D). p values were calculated using the Mann-Whitney test.
doi:10.1371/journal.pntd.0000489.g001
TLR Modulation in Filaria/TB Coinfection
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Mtb infections are highly co-endemic in many parts of the world
and often coexist within the same host, we wanted to examine the
effect of filaria-induced downmodulation of TLRs on host
responses to Mtb. In addition, the systemically circulating
microfilariae may sequester in lung capillaries when not in the
bloodstream, allowing them to be localized to the anatomic
compartment associated with Mtb infection. Activation of the
innate immune system via a number of pattern-recognition
receptors, including TLRs, is thought to be a prerequisite for
driving a protective adaptive immune response to Mtb [6]. Several
studies have shown that Mtb contains a variety of pathogen-
associated molecular patterns that serve as ligands for TLRs [6].
Based on a variety of in vitro studies, it has been suggested that
TLR2, 4, and 9 are critically involved in induction of a Th1
response following infection with Mtb [6] however, in vivo data
are not as clear cut. While some studies have shown no role for
individual TLRs in protection against Mtb [9,23,24], others have
shown that TLR2 and 9 are crucial in host resistance to Mtb
[12,25,26].
Our study reveals a new mechanism by which coexisting filarial
infections can modulate immune responses to Mtb infections.
Dually infected individuals exhibit a significant decrease in the
Figure 2. Filarial infection is associated with diminished cytokine responses to TLR2 and TLR9 ligands in latent TB patients. PBMC
from PPD+Fil2 (n= 9) and PPD+Fil+ (n= 9) patients were stimulated with TLR2 ligand (Pam3Cys) (A) or TLR9 ligand (ODN) (B) or TLR4 ligand (LPS) (C)
for 24 hours, and IL-1b, TNF-a, IL-6, IL-12p70, and IFN-c cytokine levels were measured by ELISA. Results are shown as net cytokine production over
media control. P values were calculated using the Mann-Whitney test.
doi:10.1371/journal.pntd.0000489.g002
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baseline as well as Mtb antigen-induced expression of TLR2 and 9.
While the baseline decrease in expression of TLR2 and 9 mRNA
has been shown by us previously, the impact on antigen-driven TLR
expression is striking. The diminished ability to upregulate TLR
expression following exposure to Mtb antigens suggests that
individuals with filarial infections would be impaired in their
immune response to TB and be at significant risk to develop active
disease. The examination of cytokine responses to Toll-ligands in
PPD+Fil+ patients revealed interesting differences in comparison
with PPD+Fil2 individuals. First, IFN-c and IL-12 were significantly
downregulated in PPD+Fil+ individuals, suggesting that the IL-12/
INF-c pathway in patients with coincident lymphatic filariasis and
latent TB is compromised. This has important clinical relevance, in
that it is well known that mutations in the IL-12-IFN-c–Stat1
pathway can lead to disseminated TB and atypical mycobacterial
infections in humans [27]; in addition, mice deficient in IL-12 and/
Figure 3. Treatment of filarial infection is associated with significantly enhanced cytokine responses to TLR2 and TLR9 ligands in
latent TB patients. PBMC from PPD+Fil+ (n= 9) patients, pre and post treatment, were stimulated with ligands for TLR2 (Pam3Cys) (A), TLR9 (ODN)
(B), or TLR4 (LPS) (C) for 24 hours, and IL-1b, TNF-a, IL-6, IL-12p70, and IFN-c cytokine levels were measured. Results are shown as net cytokine
production over media control. P values were calculated using the Wilcoxon signed rank test. (D) The correlation between the decrease in circulating
filarial antigen levels and the increase in TNF-a and IFN-c levels in patients with both lymphatic filariasis and latent TB following antifilarial treatment.
P values were calculated using the Spearman rank test.
doi:10.1371/journal.pntd.0000489.g003
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or IFN-c are more susceptible to Mtb infection than their WT
controls [28]. IFN-c is the central effector molecule in macrophage
elimination of bacteria, in that it induces increases in reactive
nitrogen and oxygen compounds responsible for bactericidal
activity as well as being central in the induction of autophagy, a
process recently documented to play a critical role in eliminating
mycobacteria within dendritic cells and macrophages [29,30,31].
Second, TNF-a production is significantly impaired in PPD+Fil+
individuals compared to the PPD+Fil2 individuals. TNF-a is
another cytokine that plays an important role in preventing
development of active clinical disease in individuals with latent
TB [32]. Treatment of autoimmune diseases with TNF-a
antagonists results in reactivation of Mtb and development of
clinical disease in these individuals [33]. Thus, compromised
production of TNF-a in response to Toll ligands suggests another
mechanism that predisposes individuals with filarial infection to
develop active TB. Finally, PPD+Fil+ individuals also exhibit
significantly decreased production of IL-1b and IL-6 in comparison
to PPD+Fil2 individuals in response to TLR ligands. Because IL-1b
and IL-6 are important proinflammatory cytokines necessary for
recruitment of innate effector cells such as macrophages, polymor-
phonuclear neutrophils, and NK cells to the infectious foci, the lack
of induction of these cytokines would result in compromised
activation of an effective adaptive immune response to Mtb [6]. In
addition, IL-1b has also been shown to be essential for protection
against Mtb infection in mice [34]. Thus, diminished functional
responses to TLR2 and 9 ligands could potentially disrupt multiple
mechanistic pathways operational in the control of Mtb infection.
Interestingly, treatment of filarial infection with a regimen of
DEC and albendazole, resulted in significant lowering of worm
burdens at 1 year post treatment as evidenced by the decrease in
circulating filarial antigen levels. This is accompanied by the
restoration of TLR-mediated cytokine responses to Pam3Cys and
ODN. Thus, the diminished pro-inflammatory cytokine production
observed in PPD+Fil+ individuals is abrogated following treatment,
suggesting that the associated filarial infections are the cause of
lowered cytokine responses in latent TB individuals. Moreover,
there is a direct correlation between the decrease in filarial antigen
load following treatment and the quantitative restoration of the
cytokine responses in these individuals. Our findings highlight a
novel mechanism by which a systemic helminth infection can
modulate the cytokine response to Mtb through its effects on TLRs.
Thus, alteration of TLR expression and function in filaria-
infected individuals with latent TB can have major implications in
the control of latent TB infection. In addition, these findings also
have significant implications for vaccine efficacy in helminth-
endemic countries. Vaccines requiring a pro-inflammatory
cytokine response for efficacy and those involving TLR agonists
as adjuvants may not function optimally in the presence of
helminth coinfection. The reversal of TLR modulation upon
treatment of filarial infection suggests that elimination of this
helminth infection in endemic areas might have a profound effect
in the control of TB infection.
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